Anhui Huaren Health Pharmaceutical Co., Ltd. Stock

Equities

301408

CNE100005YT4

Drug Retailers

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
12.76 CNY -0.31% Intraday chart for Anhui Huaren Health Pharmaceutical Co., Ltd. +1.92% -20.00%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2022 3.26B 452M Sales 2023 3.8B 526M Capitalization 6.38B 883M
Net income 2022 161M 22.29M Net income 2023 115M 15.92M EV / Sales 2022 * -
Net Debt 2022 280M 38.75M Net Debt 2023 32.87M 4.55M EV / Sales 2023 1.69 x
P/E ratio 2022 *
-
P/E ratio 2023
55 x
Employees 6,873
Yield 2022 *
-
Yield 2023
-
Free-Float 17.24%
More Fundamentals * Assessed data
Dynamic Chart
Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Anhui Huaren Health Pharmaceutical Co., Ltd. Approves the Election of Independent Directors CI
Certain A Shares of Anhui Huaren Health Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 2-MAR-2024. CI
Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Anhui Huaren Health Pharmaceutical Co., Ltd.(XSEC:301408) added to S&P Global BMI Index CI
Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Anhui Huaren Health Pharmaceutical Co., Ltd. completed the acquisition of Jiangsu Shenhua Pharmaceutical Co., Ltd. from Full Health (Hong Kong) Limited. CI
Anhui Huaren Health Pharmaceutical Co., Ltd. signed a letter of intent to acquire 60% stake in Zhoushan Liken Pharmaceutical Chain Co Ltd from Wang Xiangan and Zhejiang Free Trade Zone Xueyuan Project Investment Partnership for approximately CNY 110 million. CI
Anhui Huaren Health Pharma to Buy Smaller Peer For 347 Million Yuan MT
Anhui Huaren Health Pharmaceutical Co., Ltd. signed an agreement to acquire Jiangsu Shenhua Pharmaceutical Co., Ltd. from Full Health (Hong Kong) Limited for approximately CNY 350 million. CI
Huaren Health Pharma Unit Gets Drug Production License MT
Anhui Huaren Health Pharmaceutical Co., Ltd. Elects Yang Ce as A Non-Independent Director CI
More news
1 day-0.31%
1 week+1.92%
Current month+1.92%
1 month+9.06%
3 months+14.65%
6 months-26.67%
Current year-20.00%
More quotes
1 week
12.45
Extreme 12.45
12.99
1 month
10.10
Extreme 10.1
12.99
Current year
9.94
Extreme 9.94
16.30
1 year
9.94
Extreme 9.94
26.65
3 years
9.94
Extreme 9.94
28.50
5 years
9.94
Extreme 9.94
28.50
10 years
9.94
Extreme 9.94
28.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 08-05-31
Director of Finance/CFO 47 18-04-30
Director/Board Member 44 08-05-31
Members of the board TitleAgeSince
Director/Board Member 59 19-09-30
Director/Board Member 60 19-09-30
Director/Board Member 46 20-10-31
More insiders
Date Price Change Volume
24-05-08 12.76 -0.31% 3,147,200
24-05-07 12.8 +0.71% 2,852,175
24-05-06 12.71 +1.52% 3,247,509
24-04-30 12.52 +2.88% 4,245,358

End-of-day quote Shenzhen S.E., May 07, 2024

More quotes
Anhui Huaren Health Pharmaceutical Co Ltd is a China-based company mainly engaged in pharmaceutical retail, agency and terminal centralized procurement business. The pharmaceutical retail business is mainly engaged in the sales of medicines, health food and medical equipment, as well as the diagnosis and treatment of common diseases. The agency business mainly promotes and sells to downstream pharmaceutical retail enterprises. The terminal centralized procurement business mainly provides one-stop distribution services for individual pharmacies and small chain retail terminals.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 301408 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW